Baebies
Research Triangle Park, US · Delaware corporation · 5 known investors
Baebies develops multifunctional syndromic diagnostic testing using proprietary digital microfluidics, integrating molecular, immunoassay, chemistry, and coagulation testing into a single compact platform (FINDER) that runs on small-volume samples. Its products serve hospitals, clinics, pharmacies, and decentralized care settings for patients of all ages, having started with newborn and pediatric diagnostics.
BiotechDeep TechDigital HealthHealthtechMedical Devices
Founders & leadership
VP
Vamsee PamulaCo-founder
RM
Richard M. WestCo-founder
RW
Richard West
Board
DS
Dennis SachaBoard director
WA
William A. HawkinsBoard director
Investors · 5
Reported raises · per SEC filings
Form D private placements$92.8M disclosed across 5 rounds · 2013–2025
▶$2MraisedSep 2025 · 24 investors · Other Health CareRule 506(b)
▶$2MraisedSep 2025 · 24 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Dennis SachaDirector
- Vamsee PamulaExecutive Officer, Director
- Richard M. WestExecutive Officer, Director
- William A. HawkinsDirector
- Offering amount
- $10M
- Amount sold
- $2M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$37.6MraisedMay 2022 · 87 investors · Other Health CareRule 506(b)
▶$37.6MraisedMay 2022 · 87 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard M WestExecutive Officer, Director
- William A HawkinsDirector
- Nicholas NaclerioDirector
- Vamsee PamulaExecutive Officer, Director
- Dennis SachaDirector
- Offering amount
- $50M
- Amount sold
- $37.6M
- First sale
- Apr 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.9MraisedFeb 2022 · 87 investors · Other Health CareRule 506(b)
▶$11.9MraisedFeb 2022 · 87 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard M WestExecutive Officer, Director
- Dennis SachaDirector
- William A. HawkinsDirector
- Nicholas NaclerioDirector
- Vamsee PamulaExecutive Officer, Director
- Offering amount
- $11.9M
- Amount sold
- $11.9M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$28.3MraisedMay 2021 · 173 investors · Other Health CareRule 506(b)
▶$28.3MraisedMay 2021 · 173 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard M WestExecutive Officer, Director
- Vamsee PamulaExecutive Officer, Director
- Nicholas NaclerioDirector
- William A. HawkinsDirector
- Lucy MartindaleExecutive Officer
- Offering amount
- $28.5M
- Amount sold
- $28.3M
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13MraisedAug 2015 · 94 investors · Other Health CareRule 506(b)
▶$13MraisedAug 2015 · 94 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard M. WestExecutive Officer, Director
- Vamsee PamulaExecutive Officer, Director
- Offering amount
- $13M
- Amount sold
- $13M
- First sale
- Aug 2013
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Baebies for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 37 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $830.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2022 | $266.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $2.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $278.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $467.8K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.9M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2019 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $225K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $215.7K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $246.6K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $232.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $231.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $224.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $215.3K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2018 | $215K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.6M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $300K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2017 | $272.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $254.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2014 | $225K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Baebies do?
- Baebies develops multifunctional syndromic diagnostic testing using proprietary digital microfluidics, integrating molecular, immunoassay, chemistry, and coagulation testing into a single compact platform (FINDER) that runs on small-volume samples. Its products serve hospitals, clinics, pharmacies, and decentralized care settings for patients of all ages, having started with newborn and pediatric diagnostics.
- Who founded Baebies?
- Baebies was founded by Vamsee Pamula, Richard M. West.
- Who are Baebies's investors?
- Baebies's investors include Duke Capital Partners, IAG Capital Partners, Rex Health Ventures, Solas BioVentures, VentureSouth.
- How much funding has Baebies raised?
- Baebies has disclosed $92.8M raised across 5 rounds.
- Where is Baebies headquartered?
- Baebies is headquartered in Research Triangle Park, US.